Integrated Filing — IndAS



General information about company

Scrip Code 512529
NSE Symbol VIYASH
MSEI Symbol NA
ISIN INE807F01027
Name of company Viyash Scientific limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 13-11-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 02-11-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Pharmaceuticals
Start date and time of board meeting 13-11-2026   15:30:00
End date and time of board meeting 13-11-2026   17:15:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 13-11-2026
Indicate Company website link for updated RPT policy of the Company https://www.viyash.com/CorporateGovernance
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not Applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 39,065.00 74,434.00
Other income 1,074.00 2,533.00
Total income 40,139.00 76,967.00
2 Expenses
(a) Cost of materials consumed 20,901.00 37,432.00
(b) Purchases of stock-in-trade 852.00 1,194.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (3,460.00) (4,010.00)
(d) Employee benefit expense 8,998.00 16,062.00
(e) Finance costs 217.00 361.00
(f) Depreciation, depletion and amortisation expense 1,620.00 4,861.00
(f) Other Expenses
1 Other Expenses 7,820.00 15,087.00
Total other expenses 7,820.00 15,087.00
Total expenses 36,948.00 70,987.00
3 Total profit before exceptional items and tax 3,191.00 5,980.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 3,191.00 5,980.00
6 Tax expense
7 Current tax 870.00 1,332.00
8 Deferred tax (15.00) 220.00
9 Total tax expenses 855.00 1,552.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 2,336.00 4,428.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 2,336.00 4,428.00
17 Other comprehensive income net of taxes (1.00) (28.00)
18 Total Comprehensive Income for the period 2,335.00 4,400.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 8,832.00 8,832.00
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.53 1.01
Diluted earnings (loss) per share from continuing operations 0.52 0.98
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.53 1.01
Diluted earnings (loss) per share from continuing and discontinued operations 0.52 0.98
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) The published financial results, comprising the Balance Sheet, Statement of Profit and Loss, and Statement of Cash Flows, have been prepared and presented in accordance with the requirements of the Companies Act, 2013 and applicable Indian Accounting Standards (Ind AS). For the purpose of XBRL filing, certain line items have been further disaggregated and mapped to the prescribed taxonomy fields in the reporting template. Such presentation adjustments have been made solely for reporting and tagging purposes and do not affect the amounts disclosed in the published financial results. Accordingly, the amounts reported in the XBRL filing have been presented in a manner that conforms to the prescribed taxonomy requirements while remaining consistent with the financial results for the quarter and half-year ended 30 September 2026.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 84,368.00
Capital work-in-progress 1,757.00
Investment property
Goodwill 33,470.00
Other intangible assets 448.00
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 1,37,978.00
Trade receivables, non-current
Loans, non-current 19,574.00
Other non-current financial assets
1 Other non-current financial assets 1,274.00
Total of other non-current financial assets 1,274.00
Total non-current financial assets 1,58,826.00
Deferred tax assets (net)
Other non-current assets
1 Other non-current assets 412.00
2 Income tax assets (net) 910.00
Total of other non-current assets 1,322.00
Total non-current assets 2,80,191.00
2 Current assets
Inventories 37,138.00
Current financial asset
Current investments 6.00
Trade receivables, current 57,744.00
Cash and cash equivalents 1,034.00
Bank balance other than cash and cash equivalents 1,234.00
Loans, current 0.00
Other current financial assets
Total of other current financial assets 60.00
Total current financial assets 60,078.00
Current tax assets (net)
Other current assets
1 Other current assets 10,219.00
Total of other current assets 10,219.00
Total current assets 1,07,435.00
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 3,87,626.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 8,832.00
Other equity 3,25,636.00
Total equity attributable to owners of parent 3,34,468.00
Non controlling interest
Total equity 3,34,468.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 415.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
1 Lease liabilities 97.00
2 Other financial liabilities 108.00
Total of other non-current financial liabilities 205.00
Total non-current financial liabilities 620.00
Provisions, non-current 1,779.00
Deferred tax liabilities (net) 2,751.00
Deferred government grants, Non-current
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 5,150.00
Current liabilities
Current financial liabilities
Borrowings, current 4,791.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 2,820.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 34,444.00
Total Trade payable 37,264.00
Other current financial liabilities
1 Lease liabilities 24.00
2 Other financial liabilities 1,976.00
Total of other current financial liabilities 2,000.00
Total current financial liabilities 44,055.00
Other current liabilities 1,232.00
1 Other current liabilities 1,232.00
Total of other current liabilities 1,232.00
Provisions, current 628.00
Current tax liabilities (Net) 2,093.00
Deferred government grants, Current
Total current liabilities 48,008.00
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 53,158.00
Total equity and liabilites 3,87,626.00
Disclosure of notes on assets and liabilities Textual Information(1)



Text Block

Textual Information(1) The published financial results, comprising the Balance Sheet, Statement of Profit and Loss, and Statement of Cash Flows, have been prepared and presented in accordance with the requirements of the Companies Act, 2013 and applicable Indian Accounting Standards (Ind AS). For the purpose of XBRL filing, certain line items have been further disaggregated and mapped to the prescribed taxonomy fields in the reporting template. Such presentation adjustments have been made solely for reporting and tagging purposes and do not affect the amounts disclosed in the published financial results. Accordingly, the amounts reported in the XBRL filing have been presented in a manner that conforms to the prescribed taxonomy requirements while remaining consistent with the financial results for the quarter and half-year ended 30 September 2026.



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Re-measurement loss on defined benefits plans (2.00) (39.00)
2 Fair value gain / (loss) from investment in equity instruments 0.00 1.00
Total Amount of items that will not be reclassified to profit and loss (2.00) (38.00)
2 Income tax relating to items that will not be reclassified to profit or loss (1.00) (10.00)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income (1.00) (28.00)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 5,980.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 361.00
Adjustments for decrease (increase) in inventories (7,851.00)
Adjustments for decrease (increase) in trade receivables, current (3,765.00)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 3,420.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 4,861.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (285.00)
Adjustments for dividend income 0.00
Adjustments for interest income 1,854.00
Adjustments for share-based payments 5,925.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow (34.00)
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items (102.00)
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 676.00
Net cash flows from (used in) operations 6,656.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 143.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 6,513.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 97.00
Purchase of property, plant and equipment 3,583.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 10,624.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 96.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 171.00
Net cash flows from (used in) investing activities (13,843.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 4,648.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 2,251.00
Repayments of borrowings 268.00
Payments of lease liabilities 44.00
Dividends paid 0.00
Interest paid 320.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities 6,267.00
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (1,063.00)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (1,063.00)
Cash and cash equivalents cash flow statement at beginning of period 2,097.00
Cash and cash equivalents cash flow statement at end of period 1,034.00





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Unaudited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 SRBC & CO LLP Yes 28-02-2029


Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Alivira Saude Animal Ltda, Brazil Fellow subsidiary Any other transaction Loans and Advances NA 0.00 2,729.10 0.00
2 Alivira Saude Animal Ltda, Brazil Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Fellow subsidiary Any other transaction Loans and Advances NA 0.00 2,729.10 0.00
3 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Trade Payable NA 0.00 67.00 219.80
4 Alivira Animal Health Limited, India Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction Trade Payable NA 0.00 1.20 0.80
5 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Trade Payable NA 0.00 8,597.10 7,168.70
6 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction Trade Payable NA 0.00 1,778.60 1,424.50
7 Alivira Animal Health Limited, Ireland Bremer Pharma GmbH, Germany Wholly owned subsidiary Any other transaction Trade Payable NA 0.00 20.90 45.80
8 Alivira Animal Health Limited, Ireland Alivira NV Wholly owned subsidiary Any other transaction Trade Payable NA 0.00 152.00 23.70
9 Alivira Animal Health Limited, Ireland Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction Trade Payable NA 0.00 207.70 406.10
10 Alivira Italia S.R.L. Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable NA 0.00 650.60 642.00
11 Alivira Italia S.R.L. Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable NA 0.00 445.30 624.70
12 Alivira Italia S.R.L. Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Trade Payable NA 0.00 14.40 55.90
13 Alivira Saude Animal Ltda, Brazil Alivira Animal Health Limited, India Intermediary holding Any other transaction Trade Payable NA 0.00 587.30 144.20
14 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable NA 0.00 285.90 0.00
15 Bremer Pharma GmbH, Germany Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable NA 0.00 0.70 0.00
16 Alivira NV Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable NA 0.00 1.90 58.90
17 Alivira NV Fendigo BV, Netherland Fellow subsidiary Any other transaction Trade Payable NA 0.00 143.40 255.20
18 Alivira NV Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable NA 0.00 137.60 290.20
19 Fendigo BV, Netherland Alivira NV Fellow subsidiary Any other transaction Trade Payable NA 0.00 28.30 60.20
20 Laboratorios Karizoo S.A. de C.V.,Mexico Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable NA 0.00 76.60 70.50
21 Laboratorios Karizoo S.A. de C.V.,Mexico Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Trade Payable NA 0.00 721.80 1,155.10
22 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable NA 0.00 57.10 838.70
23 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Trade Payable NA 0.00 203.60 189.90
24 N-Vet AB, Sweden Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable NA 0.00 3.90 0.70
25 Phytotherapic Solutions S.L., Spain Alivira Italia S.R.L. Fellow subsidiary Any other transaction Trade Payable NA 0.00 34.20 0.00
26 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable NA 0.00 54.20 47.30
27 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, India Intermediary holding Any other transaction Trade Payable NA 0.00 34.20 25.30
28 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable NA 0.00 18.10 18.10
29 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Bremer Pharma GmbH, Germany Fellow subsidiary Any other transaction Trade Payable NA 0.00 146.70 147.20
30 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable NA 0.00 22.00 7.20
31 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable NA 0.00 90.60 102.20
32 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable NA 0.00 66.20 55.60
33 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Trade Receivable NA 0.00 1,364.50 1,381.60
34 Alivira Animal Health Limited, India Alivira Saude Animal Ltda, Brazil Step down subsidiary Any other transaction Trade Receivable NA 0.00 538.70 143.90
35 Alivira Animal Health Limited, India Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Step down subsidiary Any other transaction Trade Receivable NA 0.00 53.30 25.50
36 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction Trade Receivable NA 0.00 70.20 185.20
37 Alivira Animal Health Limited, Ireland Alivira Italia S.R.L. Wholly owned subsidiary Any other transaction Trade Receivable NA 0.00 612.70 622.20
38 Alivira Animal Health Limited, Ireland Bremer Pharma GmbH, Germany Wholly owned subsidiary Any other transaction Trade Receivable NA 0.00 194.90 0.00
39 Alivira Animal Health Limited, Ireland Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Step down subsidiary Any other transaction Trade Receivable NA 0.00 3.30 22.80
40 Alivira Animal Health Limited, Ireland Alivira NV Wholly owned subsidiary Any other transaction Trade Receivable NA 0.00 1.90 59.60
41 Alivira Animal Health Limited, Ireland Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction Trade Receivable NA 0.00 58.10 845.40
42 Alivira Animal Health Limited, Ireland Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Wholly owned subsidiary Any other transaction Trade Receivable NA 0.00 18.50 18.80
43 Alivira Italia S.R.L. Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Trade Receivable NA 0.00 34.20 0.00
44 Alivira Saude Animal Ltda, Brazil Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Fellow subsidiary Any other transaction Trade Receivable NA 0.00 1.30 8.90
45 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Receivable NA 0.00 47.20 45.80
46 Bremer Pharma GmbH, Germany Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Any other transaction Trade Receivable NA 0.00 147.60 148.90
47 Alivira NV Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Receivable NA 0.00 149.80 23.40
48 Alivira NV Fendigo BV, Netherland Fellow subsidiary Any other transaction Trade Receivable NA 0.00 28.30 60.20
49 Fendigo BV, Netherland Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Receivable NA 0.00 11.20 22.10
50 Fendigo BV, Netherland Alivira NV Fellow subsidiary Any other transaction Trade Receivable NA 0.00 143.40 255.20
51 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, India Intermediary holding Any other transaction Trade Receivable NA 0.00 1.30 0.80
52 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Receivable NA 0.00 204.20 393.90
53 Laboratorios Karizoo, S.A., Spain Alivira Italia S.R.L. Fellow subsidiary Any other transaction Trade Receivable NA 0.00 445.30 624.70
54 Laboratorios Karizoo, S.A., Spain Alivira Saude Animal Brasil Participacoes Ltda Fellow subsidiary Any other transaction Trade Receivable NA 0.00 6.60 0.00
55 Laboratorios Karizoo, S.A., Spain Bremer Pharma GmbH, Germany Fellow subsidiary Any other transaction Trade Receivable NA 0.00 0.70 0.00
56 Laboratorios Karizoo, S.A., Spain Alivira NV Fellow subsidiary Any other transaction Trade Receivable NA 0.00 140.20 290.20
57 Laboratorios Karizoo, S.A., Spain Laboratorios Karizoo S.A. de C.V.,Mexico Fellow subsidiary Any other transaction Trade Receivable NA 0.00 76.60 70.50
58 Laboratorios Karizoo, S.A., Spain N-Vet AB, Sweden Fellow subsidiary Any other transaction Trade Receivable NA 0.00 4.10 0.70
59 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Trade Receivable NA 0.00 54.20 47.30
60 Laboratorios Karizoo, S.A., Spain Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Any other transaction Trade Receivable NA 0.00 22.20 7.20
61 Laboratorios Karizoo, S.A., Spain Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Fellow subsidiary Any other transaction Trade Receivable NA 0.00 66.60 55.70
62 Phytotherapic Solutions S.L., Spain Alivira Italia S.R.L. Fellow subsidiary Any other transaction Trade Receivable NA 0.00 14.40 55.90
63 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo S.A. de C.V.,Mexico Fellow subsidiary Any other transaction Trade Receivable NA 0.00 721.80 1,155.10
64 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Receivable NA 0.00 203.60 189.90
65 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Receivable NA 0.00 321.90 586.60
66 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Saude Animal Ltda, Brazil Fellow subsidiary Any other transaction Trade Receivable NA 0.00 108.60 126.20
67 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Trade Receivable NA 0.00 8,597.10 7,168.70
68 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Non Current Borrowing NA 0.00 47,397.10 19,574.00
69 Alivira Italia S.R.L. Alivira Animal Health Limited, Ireland Holding Any other transaction Non Current Borrowing NA 0.00 109.10 109.90
70 Alivira Italia S.R.L. Vila Vina Participacions S.L., Spain Fellow subsidiary Any other transaction Non Current Borrowing NA 0.00 109.40 43.70
71 Alivira Saude Animal Brasil Participacoes Ltda Alivira Animal Health Limited, Ireland Holding Any other transaction Non Current Borrowing NA 0.00 12,419.30 13,402.10
72 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Non Current Borrowing NA 0.00 961.60 698.90
73 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Non Current Borrowing NA 0.00 549.60 247.10
74 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Loans and Advances NA 0.00 15,026.40 26,962.90
75 Phytotherapic Solutions S.L., Spain Alivira Animal Health Limited, Ireland Holding Any other transaction Loans and Advances NA 0.00 272.50 1,275.30
76 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Loans and Advances NA 0.00 961.60 698.90
77 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Loans and Advances NA 0.00 47,397.10 19,574.00
78 Vila Vina Participacions S.L., Spain Alivira Italia S.R.L. Fellow subsidiary Any other transaction Loans and Advances NA 0.00 109.40 43.70
79 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Subsidiary Any other transaction Loans and Advances NA 0.00 549.60 247.10
80 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Trade Payable NA 0.00 471.50 234.80
81 Viyash Scientific Limited, India Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Trade Receivable NA 0.00 345.70 62.90
82 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction Non Current Borrowing NA 0.00 15,026.40 26,962.90
83 Alivira Animal Health Limited, Ireland Fendigo BV, Netherland Wholly owned subsidiary Any other transaction Non Current Borrowing NA 0.00 455.40 467.40
84 Alivira Animal Health Limited, Ireland N-Vet AB, Sweden Wholly owned subsidiary Any other transaction Non Current Borrowing NA 0.00 137.60 138.80
85 Alivira Animal Health Limited, Ireland Phytotherapic Solutions S.L., Spain Step down subsidiary Any other transaction Non Current Borrowing NA 0.00 272.00 1,275.80
86 Alivira Saude Animal Ltda, Brazil Alivira Animal Health Limited, Ireland Holding Any other transaction Non Current Borrowing NA 0.00 4,887.60 3,874.50
87 Alivira Animal Health UK Limited Alivira Animal Health Limited, Ireland Holding Any other transaction Non Current Borrowing NA 0.00 51.90 0.00
88 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, Ireland Holding Any other transaction Non Current Borrowing NA 0.00 13,188.80 13,328.80
89 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Non Current Borrowing NA 0.00 6,266.20 6,487.50
90 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Non Current Borrowing NA 0.00 2,932.90 3,136.40
91 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction Non Current Borrowing NA 0.00 803.90 173.10
92 Alivira Animal Health Limited, Ireland Alivira Italia S.R.L. Wholly owned subsidiary Any other transaction Loans and Advances NA 0.00 108.90 109.90
93 Alivira Animal Health Limited, Ireland Alivira Saude Animal Ltda, Brazil Wholly owned subsidiary Any other transaction Loans and Advances NA 0.00 4,935.50 3,866.70
94 Alivira Animal Health Limited, Ireland Alivira Saude Animal Brasil Participacoes Ltda Wholly owned subsidiary Any other transaction Loans and Advances NA 0.00 12,539.00 13,386.00
95 Alivira Animal Health Limited, Ireland Alivira Animal Health UK Limited Wholly owned subsidiary Any other transaction Loans and Advances NA 0.00 51.90 0.00
96 Alivira Animal Health Limited, Ireland Bremer Pharma GmbH, Germany Wholly owned subsidiary Any other transaction Loans and Advances NA 0.00 13,159.20 13,328.10
97 Alivira Animal Health Limited, Ireland Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Wholly owned subsidiary Any other transaction Loans and Advances NA 0.00 (1,682.90) 6,502.90
98 Alivira Animal Health Limited, Ireland Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Step down subsidiary Any other transaction Loans and Advances NA 0.00 2,943.20 3,140.90
99 Fendigo BV, Netherland Alivira Animal Health Limited, Ireland Holding Any other transaction Loans and Advances NA 0.00 436.00 435.70
100 N-Vet AB, Sweden Alivira Animal Health Limited, Ireland Holding Any other transaction Loans and Advances NA 0.00 108.00 110.30
101 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Any other transaction Loans and Advances NA 0.00 803.90 0.00
102 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Trade Receivable NA 0.00 471.50 234.80
103 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Corporate guarantee given NA 0.00 26,500.00 26,500.00
104 Viyash Scientific Limited, India Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Corporate guarantee given NA 0.00 24,818.60 24,818.60
105 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Corporate guarantee given NA 0.00 3,800.00 3,800.00
106 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable NA 0.00 3.30 20.20
107 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Payable NA 0.00 6.60 47.60
108 Laboratorios Karizoo S.A. de C.V.,Mexico Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Any other transaction Trade Payable NA 0.00 66.10 0.00
109 Laboratorios Karizoo, S.A., Spain Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Fellow subsidiary Any other transaction Trade Receivable NA 0.00 6.60 47.60
110 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo S.A. de C.V.,Mexico Fellow subsidiary Any other transaction Trade Receivable NA 0.00 66.10 0.00
111 APPCO PHARMA LLC Viyash Scientific Limited, India Holding Any other transaction Trade Payable NA 0.00 958.50 524.30
112 Viyash Scientific Limited, India APPCO PHARMA LLC Subsidiary Any other transaction Trade Receivable NA 0.00 958.50 524.30
113 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Claims receivable NA 0.00 5.50 45.10
114 Alivira Animal Health Limited, Ireland Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Step down subsidiary Any other transaction Trade Receivable NA 0.00 92.10 103.00
115 Bremer Pharma GmbH, Germany Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Receivable NA 0.00 29.80 0.20
116 Alivira Animal Health Limited, Ireland Fendigo BV, Netherland Wholly owned subsidiary Any other transaction Trade Payable NA 0.00 11.00 22.10
117 Alivira Animal Health Limited, Ireland Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Wholly owned subsidiary Any other transaction Trade Payable NA 0.00 339.60 594.90
118 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Alivira Saude Animal Ltda, Brazil Fellow subsidiary Any other transaction Trade Payable NA 0.00 1.30 8.90
119 Laboratorios Karizoo, S.A., Spain Bremer Pharma GmbH, Germany Fellow subsidiary Any other transaction Trade Payable NA 0.00 29.80 0.20
120 Laboratorios Karizoo, S.A., Spain Alivira NV Fellow subsidiary Any other transaction Trade Payable NA 0.00 2.60 51.80
121 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Corporate guarantee liability NA 0.00 19.00 0.00
122 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Prepaid expenses NA 0.00 88.80 93.80
123 Alivira Animal Health Limited, Ireland Viyash Scientific Limited, India Ultimate Holding company Any other transaction Other Current Liabilities NA 0.00 14.80 30.10
124 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Corporate guarantee liability NA 0.00 88.80 93.80
125 Viyash Scientific Limited, India Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Others current financial assets NA 0.00 14.80 30.10
126 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Prepaid expenses NA 0.00 19.00 0.00
127 Viyash Scientific Limited, India Aterna Labs Private Limited Other related party Any other transaction Trade Receivable NA 0.00 14.70 35.60
128 Viyash Scientific Limited, India Aterna Labs Private Limited Other related party Any other transaction Advance to supplier NA 0.00 600.00 600.00
129 Alivira Animal Health Limited, Ireland Fendigo BV, Netherland Wholly owned subsidiary Any other transaction Trade Receivable NA 0.00 0.00 8.70
130 Alivira Italia S.R.L. Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Receivable NA 0.00 0.00 0.20
131 Fendigo BV, Netherland Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable NA 0.00 0.00 8.70
132 Alivira NV Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Receivable NA 0.00 0.00 51.80
133 Alivira Italia S.R.L. Alivira NV Fellow subsidiary Any other transaction Trade Payable NA 0.00 0.00 12.50
134 Alivira NV Alivira Italia S.R.L. Fellow subsidiary Any other transaction Trade Receivable NA 0.00 0.00 12.50
135 Alivira Saude Animal Ltda, Brazil Alivira NV Fellow subsidiary Any other transaction Trade Payable NA 0.00 0.00 12.50
136 Alivira NV Alivira Saude Animal Ltda, Brazil Fellow subsidiary Any other transaction Trade Receivable NA 0.00 0.00 12.50
137 Laboratorios Karizoo, S.A., Spain Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Any other transaction Trade Payable NA 0.00 0.00 36.00
138 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, India Intermediary holding Any other transaction Trade Payable NA 0.00 0.00 19.80
139 Laboratorios Karizoo, S.A., Spain Alivira Italia S.R.L. Fellow subsidiary Any other transaction Trade Payable NA 0.00 0.00 0.20
140 Alivira Saude Animal Ltda, Brazil Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Any other transaction Trade Payable NA 0.00 0.00 126.70
141 Alivira NV Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Fellow subsidiary Any other transaction Trade Receivable NA 0.00 0.00 12.40
142 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Alivira NV Fellow subsidiary Any other transaction Trade Payable NA 0.00 0.00 12.50
143 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction Loans and Advances NA 0.00 0.00 173.10
144 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Trade Receivable NA 0.00 0.00 35.90
145 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira NV Fellow subsidiary Any other transaction Trade Payable NA 0.00 0.00 13.00
146 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, India Intermediary holding Any other transaction Trade Receivable NA 0.00 0.00 8.10
147 N-Vet AB, Sweden Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable NA 0.00 0.00 8.50
148 Alivira NV Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Any other transaction Trade Receivable NA 0.00 0.00 13.00
149 Alivira Saude Animal Ltda, Brazil Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Fellow subsidiary Any other transaction Advances from customers NA 0.00 0.00 4,344.80
150 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Alivira Saude Animal Ltda, Brazil Fellow subsidiary Any other transaction Advance to supplier NA 0.00 0.00 4,344.80
151 Alivira Animal Health USA LLC Alivira Animal Health Limited, India Intermediary holding Any other transaction Trade Receivable NA 0.00 0.00 224.70
152 Vila Vina Participacions S.L., Spain Alivira Animal Health Limited, Ireland Holding Any other transaction Loans and Advances NA 0.00 0.00 662.70
153 Alivira Animal Health Limited, Ireland N-Vet AB, Sweden Wholly owned subsidiary Any other transaction Trade Receivable NA 0.00 0.00 9.00
154 Alivira Animal Health Limited, Ireland Viyash Scientific Limited, India Ultimate Holding company Any other transaction Trade Payable NA 0.00 0.00 83.20
155 Alivira Animal Health Limited, Ireland Vila Vina Participacions S.L., Spain Subsidiary Any other transaction Non Current Borrowing NA 0.00 0.00 663.10
156 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction Other Current Liabilities NA 0.00 0.00 45.10
157 Alivira Animal Health Limited, India Alivira Animal Health USA LLC Step down subsidiary Any other transaction Trade Payable NA 0.00 0.00 206.10
158 Alivira Animal Health Limited, India Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Step down subsidiary Any other transaction Trade Payable NA 0.00 0.00 7.90
159 Alivira Animal Health Limited, India Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction Trade Receivable NA 0.00 0.00 19.70
160 Alivira Animal Health Limited, Ireland Alivira Italia S.R.L. Wholly owned subsidiary Interest received 0.90 NA 0.90 0.00 0.00
161 Alivira Animal Health Limited, Ireland Alivira Italia S.R.L. Wholly owned subsidiary Any other transaction Other non-operating income 8.80 NA 8.80 0.00 0.00
162 Alivira Animal Health Limited, Ireland Alivira Italia S.R.L. Wholly owned subsidiary Sale of goods or services 20.00 NA 20.00 0.00 0.00
163 Alivira Animal Health Limited, Ireland Alivira Saude Animal Ltda, Brazil Wholly owned subsidiary Interest received 203.90 NA 203.90 0.00 0.00
164 Alivira Animal Health Limited, Ireland Alivira Saude Animal Brasil Participacoes Ltda Wholly owned subsidiary Interest received 665.40 NA 665.40 0.00 0.00
165 Alivira Animal Health Limited, Ireland Alivira Animal Health UK Limited Wholly owned subsidiary Any other transaction Miscellaneous Expenses 56.30 NA 56.30 0.00 0.00
166 Alivira Animal Health Limited, Ireland Bremer Pharma GmbH, Germany Wholly owned subsidiary Interest received 151.20 NA 151.20 0.00 0.00
167 Alivira Animal Health Limited, Ireland Bremer Pharma GmbH, Germany Wholly owned subsidiary Any other transaction Other non-operating income 4.90 NA 4.90 0.00 0.00
168 Alivira Animal Health Limited, Ireland Bremer Pharma GmbH, Germany Wholly owned subsidiary Any other transaction Miscellaneous Expenses 286.70 NA 286.70 0.00 0.00
169 Alivira Animal Health Limited, Ireland Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Step down subsidiary Any other transaction Other non-operating income 35.00 NA 35.00 0.00 0.00
170 Alivira Animal Health Limited, Ireland Alivira NV Wholly owned subsidiary Any other transaction Other non-operating income 31.80 NA 31.80 0.00 0.00
171 Alivira Animal Health Limited, Ireland Alivira NV Wholly owned subsidiary Any other transaction Professional & Consulting 1.70 NA 1.70 0.00 0.00
172 Alivira Animal Health Limited, Ireland Alivira NV Wholly owned subsidiary Interest paid 10.90 NA 10.90 0.00 0.00
173 Alivira Animal Health Limited, Ireland Alivira NV Wholly owned subsidiary Sale of goods or services 27.20 NA 27.20 0.00 0.00
174 Alivira Animal Health Limited, Ireland Fendigo BV, Netherland Wholly owned subsidiary Interest paid 11.00 NA 11.00 0.00 0.00
175 Alivira Animal Health Limited, Ireland Fendigo BV, Netherland Wholly owned subsidiary Any other transaction Other non-operating income 8.70 NA 8.70 0.00 0.00
176 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Purchase of goods or services 71.30 NA 71.30 0.00 0.00
177 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Other borrowing costs 19.00 NA 19.00 0.00 0.00
178 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Interest received 1,750.00 NA 1,750.00 0.00 0.00
179 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Miscellaneous Income 173.60 NA 173.60 0.00 0.00
180 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Interest received 635.00 NA 635.00 0.00 0.00
181 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Miscellaneous Income 11.00 NA 11.00 0.00 0.00
182 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Sale of goods or services 1,377.90 NA 1,377.90 0.00 0.00
183 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Professional & Consulting 157.70 NA 157.70 0.00 0.00
184 Alivira Animal Health Limited, Ireland Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction Professional & Consulting 193.80 NA 193.80 0.00 0.00
185 Alivira Animal Health Limited, Ireland Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Wholly owned subsidiary Dividend received 2,330.50 NA 2,330.50 0.00 0.00
186 Alivira Animal Health Limited, Ireland Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction Other non-operating income 189.80 NA 189.80 0.00 0.00
187 Alivira Animal Health USA LLC Alivira Animal Health Limited, India Intermediary holding Any other transaction Other non-operating income 222.80 NA 222.80 0.00 0.00
188 Alivira Animal Health Limited, India Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction Other non-operating income 8.20 NA 8.20 0.00 0.00
189 Alivira Animal Health Limited, India Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction Miscellaneous Expenses 0.80 NA 0.80 0.00 0.00
190 Alivira Animal Health Limited, India Alivira Saude Animal Ltda, Brazil Step down subsidiary Sale of goods or services 143.90 NA 143.90 0.00 0.00
191 Alivira Animal Health Limited, Ireland Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction R&D Exp 0.20 NA 0.20 0.00 0.00
192 Alivira Animal Health Limited, Ireland Laboratorios Karizoo, S.A., Spain Step down subsidiary Sale of goods or services 590.60 NA 590.60 0.00 0.00
193 Alivira Animal Health Limited, India Laboratorios Karizoo, S.A., Spain Step down subsidiary Sale of goods or services 11.50 NA 11.50 0.00 0.00
194 Alivira Animal Health Limited, Ireland N-Vet AB, Sweden Wholly owned subsidiary Interest paid 1.00 NA 1.00 0.00 0.00
195 Alivira Animal Health Limited, Ireland N-Vet AB, Sweden Wholly owned subsidiary Any other transaction Other non-operating income 22.00 NA 22.00 0.00 0.00
196 Alivira Animal Health Limited, Ireland Phytotherapic Solutions S.L., Spain Step down subsidiary Interest paid 22.60 NA 22.60 0.00 0.00
197 Alivira Animal Health Limited, Ireland Phytotherapic Solutions S.L., Spain Step down subsidiary Any other transaction Other non-operating income 6.10 NA 6.10 0.00 0.00
198 Phytotherapic Solutions S.L., Spain Alivira Animal Health Limited, Ireland Holding Any other transaction Professional & Consulting 6.20 NA 6.20 0.00 0.00
199 Fendigo BV, Netherland Alivira Animal Health Limited, Ireland Holding Any other transaction Miscellaneous Expenses 8.70 NA 8.70 0.00 0.00
200 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, India Intermediary holding Any other transaction Other Operating income 0.00 NA 0.80 13-11-2026 0.80 0.00 0.00
201 Alivira Italia S.R.L. Vila Vina Participacions S.L., Spain Fellow subsidiary Interest paid 1.40 NA 1.40 0.00 0.00
202 Alivira Italia S.R.L. Laboratorios Karizoo, S.A., Spain Fellow subsidiary Purchase of goods or services 486.40 NA 486.40 0.00 0.00
203 Alivira Italia S.R.L. Phytotherapic Solutions S.L., Spain Fellow subsidiary Purchase of goods or services 56.50 NA 56.50 0.00 0.00
204 Alivira Italia S.R.L. Alivira Animal Health Limited, Ireland Holding Purchase of goods or services 19.80 NA 19.80 0.00 0.00
205 Alivira Italia S.R.L. Alivira Animal Health Limited, Ireland Holding Interest paid 0.90 NA 0.90 0.00 0.00
206 Alivira Italia S.R.L. Alivira Animal Health Limited, Ireland Holding Any other transaction Professional & Consulting 8.90 NA 8.90 0.00 0.00
207 Alivira Italia S.R.L. Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Professional & Consulting 50.90 NA 50.90 0.00 0.00
208 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, Ireland Holding Interest paid 149.90 NA 149.90 0.00 0.00
209 Alivira Animal Health Limited, Ireland Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Wholly owned subsidiary Interest received 118.90 NA 118.90 0.00 0.00
210 Bremer Pharma GmbH, Germany Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Professional & Consulting 1.00 NA 1.00 0.00 0.00
211 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, Ireland Holding Any other transaction Other Operating income 207.10 NA 207.10 0.00 0.00
212 Fendigo BV, Netherland Alivira NV Fellow subsidiary Any other transaction Freight & forwarding 81.30 NA 81.30 0.00 0.00
213 Fendigo BV, Netherland Alivira NV Fellow subsidiary Any other transaction Miscellaneous Expenses 32.60 NA 32.60 0.00 0.00
214 Fendigo BV, Netherland Alivira NV Fellow subsidiary Any other transaction Professional & Consulting 21.50 NA 21.50 0.00 0.00
215 Alivira Animal Health Limited, Ireland Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Wholly owned subsidiary Purchase of goods or services 724.80 NA 724.80 0.00 0.00
216 Alivira NV Laboratorios Karizoo, S.A., Spain Fellow subsidiary Purchase of goods or services 708.20 NA 708.20 0.00 0.00
217 Alivira NV Alivira Animal Health Limited, Ireland Holding Purchase of goods or services 27.20 NA 27.20 0.00 0.00
218 Alivira NV Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Professional & Consulting 68.70 NA 68.70 0.00 0.00
219 Alivira NV Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Salaries and Wages 50.30 NA 50.30 0.00 0.00
220 Alivira NV Alivira Italia S.R.L. Fellow subsidiary Any other transaction Salaries and Wages 0.00 NA 0.00 0.00 0.00
221 Alivira NV Alivira Saude Animal Ltda, Brazil Fellow subsidiary Any other transaction Salaries and Wages 12.60 NA 12.60 0.00 0.00
222 Alivira NV Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Any other transaction Salaries and Wages 12.60 NA 12.60 0.00 0.00
223 Alivira Animal Health Limited, Ireland Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Wholly owned subsidiary Any other transaction R&D Exp 91.40 NA 91.40 0.00 0.00
224 Alivira NV Alivira Animal Health Limited, Ireland Holding Any other transaction Professional & Consulting 20.30 NA 20.30 0.00 0.00
225 N-Vet AB, Sweden Laboratorios Karizoo, S.A., Spain Fellow subsidiary Purchase of goods or services 17.10 NA 17.10 0.00 0.00
226 N-Vet AB, Sweden Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Professional & Consulting 10.00 NA 10.00 0.00 0.00
227 Laboratorios Karizoo, S.A., Spain Alivira NV Fellow subsidiary Any other transaction Miscellaneous Expenses 0.00 NA 50.30 13-11-2026 50.30 0.00 0.00
228 Alivira Italia S.R.L. Alivira NV Fellow subsidiary Any other transaction Salaries and Wages 0.00 NA 0.00 0.00 0.00
229 Alivira Saude Animal Ltda, Brazil Alivira NV Fellow subsidiary Any other transaction Miscellaneous Expenses 12.60 NA 12.60 0.00 0.00
230 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Sale of goods or services 85.80 NA 85.80 0.00 0.00
231 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Sale of goods or services 620.40 NA 620.40 0.00 0.00
232 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo S.A. de C.V.,Mexico Fellow subsidiary Sale of goods or services 438.20 NA 438.20 0.00 0.00
233 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Subsidiary Sale of goods or services 142.00 NA 142.00 0.00 0.00
234 Vila Vina Participacions S.L., Spain Phytotherapic Solutions S.L., Spain Subsidiary Sale of goods or services 17.20 NA 17.20 0.00 0.00
235 Alivira Animal Health UK Limited Alivira Animal Health Limited, Ireland Holding Any other transaction Other non-operating income 56.30 NA 56.30 0.00 0.00
236 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, Ireland Holding Any other transaction Other non-operating income 292.30 NA 292.30 0.00 0.00
237 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Miscellaneous Expenses 3.40 NA 3.40 0.00 0.00
238 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Other non-operating income 6.40 NA 6.40 0.00 0.00
239 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Other Operating income 101.50 NA 101.50 0.00 0.00
240 Laboratorios Karizoo, S.A., Spain Laboratorios Karizoo S.A. de C.V.,Mexico Fellow subsidiary Sale of goods or services 0.70 NA 0.70 0.00 0.00
241 Alivira NV Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Any other transaction Other non-operating income 0.60 NA 0.60 0.00 0.00
242 Alivira NV Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Fellow subsidiary Any other transaction Other non-operating income 12.50 NA 12.50 0.00 0.00
243 Laboratorios Karizoo, S.A., Spain Bremer Pharma GmbH, Germany Fellow subsidiary Any other transaction Other Operating income 1.00 NA 1.00 0.00 0.00
244 Laboratorios Karizoo, S.A., Spain Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Fellow subsidiary Any other transaction Other Operating income 90.60 NA 90.60 0.00 0.00
245 Fendigo BV, Netherland Alivira NV Fellow subsidiary Any other transaction Other Operating income 777.60 NA 777.60 0.00 0.00
246 Alivira NV Fendigo BV, Netherland Fellow subsidiary Any other transaction Other non-operating income 135.30 NA 135.30 0.00 0.00
247 Alivira NV Alivira Animal Health Limited, Ireland Holding Interest received 11.00 NA 11.00 0.00 0.00
248 Laboratorios Karizoo, S.A., Spain Alivira NV Fellow subsidiary Sale of goods or services 776.90 NA 776.90 0.00 0.00
249 Laboratorios Karizoo, S.A., Spain Laboratorios Karizoo S.A. de C.V.,Mexico Fellow subsidiary Any other transaction Other Operating income 92.50 NA 92.50 0.00 0.00
250 Laboratorios Karizoo, S.A., Spain Alivira Italia S.R.L. Fellow subsidiary Sale of goods or services 486.40 NA 486.40 0.00 0.00
251 Laboratorios Karizoo, S.A., Spain Alivira Italia S.R.L. Fellow subsidiary Sale of goods or services 33.70 NA 17.20 13-11-2026 50.90 0.00 0.00
252 Phytotherapic Solutions S.L., Spain Alivira Italia S.R.L. Fellow subsidiary Sale of goods or services 56.50 NA 56.50 0.00 0.00
253 Laboratorios Karizoo, S.A., Spain Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Purchase of goods or services 13.30 NA 13.30 0.00 0.00
254 Alivira Animal Health Limited, India Laboratorios Karizoo, S.A., Spain Step down subsidiary Purchase of goods or services 0.00 NA 0.00 0.00 0.00
255 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, India Intermediary holding Purchase of goods or services 11.50 NA 11.50 0.00 0.00
256 Laboratorios Karizoo, S.A., Spain N-Vet AB, Sweden Fellow subsidiary Sale of goods or services 27.10 NA 27.10 0.00 0.00
257 Alivira Italia S.R.L. Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Other Operating income 0.20 NA 0.20 0.00 0.00
258 Laboratorios Karizoo, S.A., Spain Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Fellow subsidiary Sale of goods or services 90.60 NA 90.60 0.00 0.00
259 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Miscellaneous Expenses 0.00 NA 0.00 0.00 0.00
260 Laboratorios Karizoo, S.A., Spain Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Sale of goods or services 0.00 NA 7.30 13-11-2026 7.30 0.00 0.00
261 Laboratorios Karizoo, S.A., Spain Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Any other transaction Miscellaneous Expenses 0.00 NA 36.40 13-11-2026 36.40 0.00 0.00
262 Laboratorios Karizoo, S.A., Spain Alivira Italia S.R.L. Fellow subsidiary Any other transaction Miscellaneous Expenses 0.20 NA 0.20 0.00 0.00
263 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, Ireland Holding Any other transaction Miscellaneous Expenses 176.70 NA 176.70 0.00 0.00
264 Fendigo BV, Netherland Alivira Animal Health Limited, Ireland Holding Interest received 11.00 NA 11.00 0.00 0.00
265 Alivira Saude Animal Ltda, Brazil Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Fellow subsidiary Sale of goods or services 5,551.70 NA 5,551.70 0.00 0.00
266 Alivira Saude Animal Ltda, Brazil Alivira Animal Health Limited, India Intermediary holding Purchase of goods or services 145.10 NA 145.10 0.00 0.00
267 Alivira Saude Animal Ltda, Brazil Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow subsidiary Purchase of goods or services 240.40 NA 240.40 0.00 0.00
268 Alivira Saude Animal Ltda, Brazil Alivira Animal Health Limited, Ireland Holding Interest paid 191.00 NA 191.00 0.00 0.00
269 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Alivira Saude Animal Ltda, Brazil Fellow subsidiary Purchase of goods or services 5,551.70 NA 5,551.70 0.00 0.00
270 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Alivira Animal Health Limited, Ireland Holding Any other transaction Miscellaneous Expenses 37.10 NA 37.10 0.00 0.00
271 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Alivira NV Fellow subsidiary Any other transaction Miscellaneous Expenses 12.50 NA 12.50 0.00 0.00
272 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Miscellaneous Expenses 90.60 NA 90.60 0.00 0.00
273 Alivira Saude Animal Brasil Participacoes Ltda Alivira Animal Health Limited, Ireland Holding Interest paid 667.10 NA 667.10 0.00 0.00
274 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Sale of goods or services 1,145.00 NA 1,145.00 0.00 0.00
275 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Purchase of goods or services 716.20 NA 716.20 0.00 0.00
276 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Other Operating income 1.20 NA 1.20 0.00 0.00
277 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Any other transaction Other Operating income 62.10 NA 62.10 0.00 0.00
278 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow subsidiary Sale of goods or services 13.00 NA 13.00 0.00 0.00
279 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Any other transaction Other Operating income 2,188.10 NA 2,188.10 0.00 0.00
280 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow subsidiary Purchase of goods or services 3.20 NA 3.20 0.00 0.00
281 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Professional & Consulting 4.30 NA 4.30 0.00 0.00
282 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, India Intermediary holding Purchase of goods or services 26.00 NA 26.00 0.00 0.00
283 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, India Intermediary holding Any other transaction Miscellaneous Expenses 8.30 NA 8.30 0.00 0.00
284 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, India Intermediary holding Sale of goods or services 86.60 NA 86.60 0.00 0.00
285 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Saude Animal Ltda, Brazil Fellow subsidiary Sale of goods or services 250.60 NA 250.60 0.00 0.00
286 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Sale of goods or services 745.60 NA 745.60 0.00 0.00
287 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira NV Fellow subsidiary Any other transaction Professional & Consulting 13.00 NA 13.00 0.00 0.00
288 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Interest paid 119.50 NA 119.50 0.00 0.00
289 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Sale of goods or services 716.10 NA 716.10 0.00 0.00
290 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Purchase of goods or services 1,142.60 NA 1,142.60 0.00 0.00
291 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction Rent expense 38.50 NA 38.50 0.00 0.00
292 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction Contract labour charges 2,157.50 NA 2,157.50 0.00 0.00
293 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Professional & Consulting 91.90 NA 91.90 0.00 0.00
294 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Alivira Animal Health Limited, Ireland Holding Interest paid 155.90 NA 155.90 0.00 0.00
295 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Professional & Consulting 149.20 NA 149.20 0.00 0.00
296 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Other non-operating income 3.40 NA 3.40 0.00 0.00
297 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Professional & Consulting 119.30 NA 119.30 0.00 0.00
298 N-Vet AB, Sweden Alivira Animal Health Limited, Ireland Holding Interest received 0.80 NA 0.80 0.00 0.00
299 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Interest received 12.30 NA 12.30 0.00 0.00
300 Phytotherapic Solutions S.L., Spain Alivira Animal Health Limited, Ireland Holding Interest received 22.80 NA 22.80 0.00 0.00
301 Viyash Scientific Limited, India Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Miscellaneous Income 29.80 NA 29.80 0.00 0.00
302 Laboratorios Karizoo S.A. de C.V.,Mexico Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Miscellaneous Expenses 66.80 NA 66.80 0.00 0.00
303 Laboratorios Karizoo S.A. de C.V.,Mexico Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Professional & Consulting 26.50 NA 26.50 0.00 0.00
304 Laboratorios Karizoo S.A. de C.V.,Mexico Phytotherapic Solutions S.L., Spain Fellow subsidiary Purchase of goods or services 438.20 NA 438.20 0.00 0.00
305 Alivira Animal Health Limited, India Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Step down subsidiary Sale of goods or services 25.50 NA 25.50 0.00 0.00
306 Alivira Animal Health Limited, India Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Step down subsidiary Purchase of goods or services 91.10 NA 91.10 0.00 0.00
307 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Interest paid 1,750.00 NA 1,750.00 0.00 0.00
308 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Other non-operating income 3.40 NA 3.40 0.00 0.00
309 Alivira Animal Health Limited, Ireland Viyash Scientific Limited, India Ultimate Holding company Any other transaction Other borrowing costs 29.80 NA 29.80 0.00 0.00
310 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Miscellaneous Income 138.30 NA 138.30 0.00 0.00
311 Alivira NV Fendigo BV, Netherland Fellow subsidiary Any other transaction Commission Expenses 777.60 NA 777.60 0.00 0.00
312 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Subsidiary Any other transaction Rent expense 3.40 NA 3.40 0.00 0.00
313 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, India Intermediary holding Any other transaction Miscellaneous Expenses 8.20 NA 8.20 0.00 0.00
314 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Rent expense 7.20 NA 7.20 0.00 0.00
315 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Interest paid 9.20 NA 9.20 0.00 0.00
316 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Professional & Consulting 147.40 NA 147.40 0.00 0.00
317 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Rent expense 3.30 NA 3.30 0.00 0.00
318 Vila Vina Participacions S.L., Spain Alivira Italia S.R.L. Fellow subsidiary Interest received 1.40 NA 1.40 0.00 0.00
319 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Miscellaneous Expenses 4.30 NA 4.30 0.00 0.00
320 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Purchase of goods or services 114.70 NA 114.70 0.00 0.00
321 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Interest paid 12.30 NA 12.30 0.00 0.00
322 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Freight & forwarding 3.00 NA 3.00 0.00 0.00
323 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow subsidiary Purchase of goods or services 620.40 NA 620.40 0.00 0.00
324 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow subsidiary Any other transaction Analytical charges 28.90 NA 28.90 0.00 0.00
325 Phytotherapic Solutions S.L., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Professional & Consulting 17.20 NA 17.20 0.00 0.00
326 Phytotherapic Solutions S.L., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Miscellaneous Expenses 3.50 NA 3.50 0.00 0.00
327 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, Ireland Holding Any other transaction Professional & Consulting 5.00 NA 5.00 0.00 0.00
328 N-Vet AB, Sweden Alivira Animal Health Limited, Ireland Holding Any other transaction Professional & Consulting 8.90 NA 8.90 0.00 0.00
329 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Subsidiary Interest received 9.20 NA 9.20 0.00 0.00
330 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Subsidiary Any other transaction Other non-operating income 7.20 NA 7.20 0.00 0.00
331 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, Ireland Holding Purchase of goods or services 598.30 NA 598.30 0.00 0.00
332 Laboratorios Karizoo, S.A., Spain Alivira NV Fellow subsidiary Purchase of goods or services 0.00 NA 26.40 13-11-2026 26.40 0.00 0.00
333 Alivira Animal Health Limited, Ireland Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Step down subsidiary Interest received 155.00 NA 155.00 0.00 0.00
334 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira NV Fellow subsidiary Any other transaction Miscellaneous Expenses 0.60 NA 0.60 0.00 0.00
335 Alivira NV Laboratorios Karizoo, S.A., Spain Fellow subsidiary Sale of goods or services 26.40 NA 26.40 0.00 0.00
336 Alivira Animal Health Limited, Ireland Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Step down subsidiary Any other transaction Other non-operating income 151.70 NA 151.70 0.00 0.00
337 N-Vet AB, Sweden Alivira Animal Health Limited, Ireland Holding Any other transaction Miscellaneous Expenses 13.10 NA 13.10 0.00 0.00
338 Vila Vina Participacions S.L., Spain Alivira Animal Health Limited, Ireland Holding Interest received 9.50 NA 9.50 0.00 0.00
339 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Subsidiary Any other transaction Other Operating income 5.50 NA 5.50 0.00 0.00
340 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Sale of goods or services 71.30 NA 71.30 0.00 0.00
341 Vila Vina Participacions S.L., Spain Phytotherapic Solutions S.L., Spain Subsidiary Any other transaction Other Operating income 3.50 NA 3.50 0.00 0.00
342 Alivira Animal Health Limited, Ireland Vila Vina Participacions S.L., Spain Subsidiary Interest paid 9.20 NA 9.20 0.00 0.00
343 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Purchase of goods or services 3,883.40 NA 3,883.40 0.00 0.00
344 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Other borrowing costs 95.00 NA 95.00 0.00 0.00
345 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Professional & Consulting 78.60 NA 78.60 0.00 0.00
346 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Interest paid 634.00 NA 634.00 0.00 0.00
347 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction Other borrowing costs 11.00 NA 11.00 0.00 0.00
348 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction Other non-operating income 158.90 NA 158.90 0.00 0.00
349 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Purchase of goods or services 1,377.90 NA 1,377.90 0.00 0.00
350 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Sale of goods or services 3,883.40 NA 3,883.40 0.00 0.00
351 Alivira Animal Health Limited, India Alivira Animal Health USA LLC Step down subsidiary Any other transaction Professional & Consulting 206.10 NA 206.10 0.00 0.00
352 Alivira Animal Health Limited, India Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Step down subsidiary Any other transaction Other non-operating income 7.90 NA 7.90 0.00 0.00
353 Viyash Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Other non-operating income 59.20 NA 59.20 0.00 0.00
354 Alivira Animal Health Limited, India Viyash Scientific Limited, India Holding Any other transaction Rent expense 59.20 NA 59.20 0.00 0.00
355 Viyash Scientific Limited, India Appco Pharma LLC Subsidiary Sale of goods or services 2,302.50 NA 2,302.50 0.00 0.00
356 Appco Pharma LLC Viyash Scientific Limited, India Holding Any other transaction Salaries and Wages 66.40 NA 66.40 0.00 0.00
357 Appco Pharma LLC Viyash Scientific Limited, India Holding Any other transaction Analytical charges 548.30 NA 548.30 0.00 0.00
358 Appco Pharma LLC Viyash Scientific Limited, India Holding Purchase of goods or services 1,687.80 NA 1,687.80 0.00 0.00
359 Viyash Scientific Limited, India Aterna Labs Private Limited Other related party Sale of goods or services 17.70 NA 17.70 0.00 0.00
360 Viyash Scientific Limited, India Aterna Labs Private Limited Other related party Interest received 30.00 NA 30.00 0.00 0.00
361 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Dividend expenses 2,273.00 NA 2,273.00 0.00 0.00
362 Alivira Animal Health Limited, Ireland Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction Sale of IAUD 0.00 NA 11.30 13-11-2026 11.30 0.00 0.00
363 Viyash Scientific Limited, India Revati Kasture Independent Directors Any other transaction Director sitting fee 9.00 NA 9.00 0.00 0.00
364 Viyash Scientific Limited, India Milind Sarwate Independent Directors Any other transaction Director sitting fee 11.00 NA 11.00 0.00 0.00
365 Viyash Scientific Limited, India Dr. Kamal Sharma Independent Directors Any other transaction Director sitting fee 12.00 NA 12.00 0.00 0.00
366 Alivira Animal Health Limited, India Dr. Kamal Sharma Independent Directors Any other transaction Director sitting fee 2.00 NA 2.00 0.00 0.00
367 Viyash Scientific Limited, India Dr. Kamal Sharma Independent Directors Any other transaction Director Commission 22.00 NA 22.00 0.00 0.00
368 Viyash Scientific Limited, India Milind Sarwate Independent Directors Any other transaction Director Commission 24.00 NA 24.00 0.00 0.00
369 Alivira Animal Health Limited, Ireland Gregory Andrews John Independent Directors Any other transaction Director Commission 9.50 NA 9.50 0.00 0.00
370 Alivira Animal Health Limited, Ireland Dr Fabian Kauche Independent Directors Any other transaction Director Commission 9.40 NA 9.40 0.00 0.00
Total value of transaction during the reporting period 62,585.80